Z-2227-2012 Class III Terminated
FDA device recall Z-2227-2012 was initiated by Beckman Coulter Inc. on Oct 11, 2011 and is designated Class III. Reason for recall: A recall was initiated because Beckman Coulter has identified a negative bias in test results when comparing elevated Total T3 patient samples diluted with Sample Diluent A to samples diluted with… The recall status is terminated (terminated Mar 14, 2013). Affected quantity: 117,385 units total (33,918 units in US).
Recall details
- Product Type
- Devices
- Report Date
- Aug 29, 2012
- Initiation Date
- Oct 11, 2011
- Termination Date
- Mar 14, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 117,385 units total (33,918 units in US)
Product description
Access Total T3 Reagent, PN: 33830 The Access Total T3 assay is used for the quantitative determination of triiodothyronine (T3) levels in human serum and plasma in the assessment of thyroid function and diagnosis of thyroid disorders when T3 levels are between 0.1 and 8.0 ng/mL.
Reason for recall
A recall was initiated because Beckman Coulter has identified a negative bias in test results when comparing elevated Total T3 patient samples diluted with Sample Diluent A to samples diluted with Access Total T3 Calibrator S0.
Distribution pattern
Worldwide Distribution - USA (nationwide), Canada, and internationally.
Code information
All Lots
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2227-2012
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026